served on scientific advisory panels and/or speakers bureaus and served as a consultant to and/or received research support from Amgen, AstraZeneca, Boehringer, Bristol-Myers Squibb, Eli Lilly, Merck Sharp & Dohme, Novo Nordisk and Sanofi
Shima Hadidchi MD Family Practice, we believe in a personalized and comprehensive approach to weight management and overall health
Along with a significant pool of preclinical data on the effect of GLP-1RAs (including exendin-4) on PD models in experimental animals, showing a decrease in the loss of dopaminergic neurons and accumulation of -synuclein in the brain, a decrease in mitochondrial dysfunction and expression of pro-inflammatory mediators such as tumor necrosis factor (TNF)- and interleukin IL-1 [61], promising data from clinical studies on the use of GLP-1RAs in PD have been obtained [62]
"It's not true that there's something inherent in peptides that makes it not susceptible to the conventional aspects of FDA regulation," Peter Lurie with the science advocacy group Center for Science in the Public Interest told Business Insider
